Invensify, Inc. and Senpex announced a partnership to enhance the delivery of temperature-sensitive pharmaceuticals. Through this collaboration, Senpex will incorporate Invensify's Insuridge™ shipping container into their logistics operations.
The Insuridge temperature-controlled shipping container serves as an innovative alternative to passive shippers that rely on dry ice or phase-change materials. By leveraging semiconductor technology, the Insuridge container ensures the protection of temperature-sensitive materials such as DNA, RNA, intact cells, pharmaceuticals, and more during transport.
"We are thrilled to partner with Senpex and provide them with our cutting-edge Insuridge shipping containers," said Faizan Ahmed, CEO and Founder of Invensify. "Our solution aligns perfectly with Senpex's commitment to embracing advanced technologies and improving the reliability of their courier services. Together, we are transforming the last-mile delivery of temperature-sensitive pharmaceuticals, ensuring the integrity and safety of these critical products."
Senpex has a proven track record of success, having completed over 500,000 successful deliveries since its inception in 2017. The company offers a wide range of courier and logistics services to various industries. By incorporating Invensify's Insuridge shipping containers, Senpex takes a significant step forward in addressing the challenges of ensuring cold chain integrity during deliveries.
Anar Mammadov, CEO and co-founder of Senpex Technology, expressed enthusiasm about the partnership. "Senpex has always prioritized the adoption of innovative technology to enhance our courier service and streamline operations," said Mammadov. "Partnering with Invensify to provide FDA 21 CFR compliant tracking and monitoring of temperature-sensitive pharmaceutical shipments was a natural decision. We believe this collaboration will significantly contribute to our mission of delivering affordable, convenient, and trusted shipping services to industries of all sizes."